MX2021000779A - Nuevas particulas portadoras para formulaciones de polvo seco para inhalacion. - Google Patents

Nuevas particulas portadoras para formulaciones de polvo seco para inhalacion.

Info

Publication number
MX2021000779A
MX2021000779A MX2021000779A MX2021000779A MX2021000779A MX 2021000779 A MX2021000779 A MX 2021000779A MX 2021000779 A MX2021000779 A MX 2021000779A MX 2021000779 A MX2021000779 A MX 2021000779A MX 2021000779 A MX2021000779 A MX 2021000779A
Authority
MX
Mexico
Prior art keywords
inhalation
dry powder
carrier particles
powder formulations
novel carrier
Prior art date
Application number
MX2021000779A
Other languages
English (en)
Spanish (es)
Inventor
Tomaso Guidi
Amrit Paudel
Sarah Elisabeth Zellnitz
Pinto Joana Filipa Fernandes Teixeira
Original Assignee
Chiesi Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa
Publication of MX2021000779A publication Critical patent/MX2021000779A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
MX2021000779A 2018-07-27 2019-07-24 Nuevas particulas portadoras para formulaciones de polvo seco para inhalacion. MX2021000779A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18186078 2018-07-27
PCT/EP2019/069943 WO2020020957A1 (en) 2018-07-27 2019-07-24 Novel carrier particles for dry powder formulations for inhalation

Publications (1)

Publication Number Publication Date
MX2021000779A true MX2021000779A (es) 2021-03-31

Family

ID=63079833

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021000779A MX2021000779A (es) 2018-07-27 2019-07-24 Nuevas particulas portadoras para formulaciones de polvo seco para inhalacion.

Country Status (11)

Country Link
US (1) US11813360B2 (pt)
EP (1) EP3829641B1 (pt)
JP (1) JP7439084B2 (pt)
KR (1) KR20210040102A (pt)
CN (1) CN112469443B (pt)
AU (1) AU2019311268A1 (pt)
BR (1) BR112021001402A2 (pt)
CA (1) CA3105265A1 (pt)
MA (1) MA53324A (pt)
MX (1) MX2021000779A (pt)
WO (1) WO2020020957A1 (pt)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
AU2001291721A1 (en) * 2000-08-25 2002-03-04 Merck Patent G.M.B.H Powdered mannitol and mannitol-containing compositions
AU2002211018B2 (en) 2000-11-06 2004-08-05 Asahi Kasei Kabushiki Kaisha Cellulosic particle for pharmaceutical preparation
WO2002098348A2 (en) 2001-06-01 2002-12-12 Eli Lilly And Company Glp-1 formulations with protracted time action
ES2359576T5 (es) 2002-07-31 2020-03-03 Chiesi Farm Spa Inhalador de polvo
PT1610878E (pt) 2003-02-21 2014-12-03 Univ Bath Processo para a produção de partículas
EP1830815A1 (en) * 2004-12-21 2007-09-12 Pfizer Products Incorporated Enteric coated azithromycin multiparticulates
GB0705159D0 (en) 2007-03-19 2007-04-25 Prosonix Ltd Process for making crystals
GB0711680D0 (en) 2007-06-18 2007-07-25 Prosonix Ltd Process
MX2010012039A (es) * 2008-05-09 2010-11-30 Gruenenthal Gmbh Proceso para la preparacion de una formulacion de polvo intermedia y una forma de dosificacion solida final bajo el uso de un paso de congelacion por rocio.
CN102149437B (zh) 2008-07-18 2017-02-15 普罗索尼克斯有限公司 用于提高氟替卡松颗粒结晶度的方法
EP2216327A1 (en) 2009-02-06 2010-08-11 CHIESI FARMACEUTICI S.p.A. Benzoic acid (1-phenyl-2-pyridin-4-yl)ethyl esters as phosphodiesterase inhibitors
CN102811715A (zh) 2009-12-08 2012-12-05 悉尼大学 可吸入制剂
EP2601973A1 (en) 2011-12-09 2013-06-12 Laboratoires SMB SA Dry powder formulation of azole derivative for inhalation
US9554992B2 (en) * 2014-06-09 2017-01-31 Chiesi Farmaceutici S.P.A. Inhalation particles comprising a combination of an anticholinergic, a corticosteroid and a beta-adrenergic

Also Published As

Publication number Publication date
EP3829641A1 (en) 2021-06-09
AU2019311268A1 (en) 2021-02-11
EP3829641B1 (en) 2024-05-22
CA3105265A1 (en) 2020-01-30
US20210290540A1 (en) 2021-09-23
WO2020020957A1 (en) 2020-01-30
BR112021001402A2 (pt) 2021-04-27
US11813360B2 (en) 2023-11-14
CN112469443B (zh) 2024-04-16
CN112469443A (zh) 2021-03-09
JP2021531948A (ja) 2021-11-25
MA53324A (fr) 2021-06-09
JP7439084B2 (ja) 2024-02-27
KR20210040102A (ko) 2021-04-12

Similar Documents

Publication Publication Date Title
PH12018500707A1 (en) Anti-human cd19 antibodies with high affinity
SG10201907164SA (en) Rna containing composition for treatment of tumor diseases
MX336414B (es) Proceso de preparacion de particulas portadoras para polvos secos para inhalacion.
MX2015012414A (es) Sal de omecamtiv mecarbilo y proceso para preparar la sal.
MX2012012045A (es) Proceso para proporcionar particulas con cargas electrostaticas reducidas.
JO3154B1 (ar) عوامل مضادة لـ trpv4
PH12018500852B1 (en) Novel cryptophycin compounds and conjugates, their preparation and their therapeutic use
SG10201810660QA (en) Alkyl derivatives of 1-oxa-4,9-diazaspiro undecane compounds having multimodal activity against pain
MX2020009416A (es) Nuevos reactivos a base de fosforo (v), procesos para su preparacion y su uso en la elaboracion de compuestos de organofosforo (v) estereo-definidos.
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
IN2015DN03336A (pt)
MX2020005478A (es) Compuestos de sulfonamida y usos de los mismos.
MX2018000743A (es) Granulos de manitol para compresion directa.
MX2015013254A (es) Composiciones de agente activo retinoide particuladas, secas y finas y formulaciones topicas que incluyen las mismas.
TN2017000018A1 (en) [1,2,4]triazolo[4,3-b]pyridazines for use in the treatment of proliferative diseases.
GB2514741A (en) Composition for use as a paint binder
IN2013MU01177A (pt)
MX2018014790A (es) Formulacion combinada de tres compuestos antivirales.
MX2021000779A (es) Nuevas particulas portadoras para formulaciones de polvo seco para inhalacion.
PH12018502139A1 (en) Phosphaplatin liquid formulations
EP3600366A4 (en) PROCESS FOR THE PREPARATION OF PROBIOTIC POWDER FORMULATIONS FOR MONOGASTRIC ANIMALS
IN2014DN10135A (pt)
MX2019013570A (es) Particulas portadoras novedosas para formulaciones de polvo seco para inhalacion.
GEP20196944B (en) Process for preparing the inhalation formulations
MX2022003427A (es) Particulas portadoras novedosas para formulaciones de polvo seco para inhalacion.